Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly EPS (Basic) came in at $0.02 in Q1 2026, down 81.26% year-on-year from $0.11 in Q1 2025, and down 98.69% quarter-over-quarter from $1.62 in Q4 2025.
Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.02 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 81.26% year-over-year to $0.02 in Q1 2026; TTM through Mar 2026 was $2.2, a 60.55% increase from a year earlier, with the FY2025 full-year figure at $2.32, up 69.96% from the prior year.
- EPS (Basic) fell to $0.02 in Q1 2026 per ACAD's latest filing, from $1.62 in the prior quarter.
- Across five years, EPS (Basic) topped out at $279.56 in Q4 2023 and bottomed at -$396.85 in Q3 2023.
- The 5-year median for EPS (Basic) is $0.11 (2025), against an average of -$43.74.
- Across the five-year window, EPS (Basic) plunged 186442.28% in 2022 and soared 208.54% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$257.57 in 2022, then surged by 208.54% to $279.56 in 2023, then sank by 99.69% to $0.87 in 2024, then jumped by 87.34% to $1.62 in 2025, then tumbled by 98.69% to $0.02 in 2026.
- Per Business Quant, the three latest ACAD EPS (Basic) figures stand at $0.02 (Q1 2026), $1.62 (Q4 2025), and $0.43 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 1.62 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 279.56 |
| Sep 30, 2023 | -396.85 |
| Jun 30, 2023 | 6.82 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | -257.57 |
| Sep 30, 2022 | -167.86 |
| Jun 30, 2022 | -210.39 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -0.27 |